GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.25
Bid: 5.20
Ask: 5.30
Change: 0.00 (0.00%)
Spread: 0.10 (1.923%)
Open: 5.20
High: 5.30
Low: 5.20
Prev. Close: 5.25
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Wed, 26th Feb 2020 16:15

Thursday 27 February 
Standard CharteredFull Year Results (at 0415 GMT)
WPP Full Year Results
Flutter EntertainmentFull Year Results
Watches of SwitzerlandTrading Statement
Aston Martin LagondaFull Year Results
RSA Insurance GroupFull Year Results
WPP Full Year Results
Reckitt BenckiserFull Year Results
PersimmonFull Year Results
MondiFull Year Results
Rentokil InitialFull Year Results
St James's PlaceFull Year Results
British American TobaccoFull Year Results
InchcapeFull Year Results
Grafton GroupFull Year Results
NetcallHalf Year Results
PPHE HotelsFull Year Results
Playtech Full Year Results
Macfarlane GroupFull Year Results
Haydale GrapheneHalf Year Results
Hikma Pharmaceuticals Full Year Results
FBD HoldingsFull Year Results
Georgia CapitalFull Year Results
Drax GroupFull Year Results
Provident FinancialFull Year Results
Vistry GroupFull Year Results
VesuviusFull Year Results
RicardoFull Year Results
EvrazFull Year Results
National ExpressFull Year Results
Amigo HoldingsFull Year Results
GenusFull Year Results
HuntingFull Year Results
James Fisher & SonsFull Year Results
Hastings Group HoldingsFull Year Results
Howden Joinery GroupFull Year Results
BakkavorFull Year Results
Verona PharmaFull Year Results
Base ResourcesFull Year Results
Friday 28 February 
London Stock Exchange GroupFull Year Results
International Consolidated Airlines GroupFull Year Results
CRHFull Year Results
RightmoveFull Year Results
Rolls-Royce HoldingsFull Year Results
Glenveagh PropertiesFull Year Results
Surface TransformsHalf Year Results
Vitec Full Year Results
EssentraFull Year Results
Tetragon Financial GroupFull Year Results
IMIFull Year Results
Man GroupFull Year Results
FoxtonsFull Year Results
ConvaTec GroupFull Year Results
Jupiter Asset ManagementFull Year Results
Monday 2 March 
Johnson Service GroupFull Year Results
Greencoat RenewablesFull Year Results
HiscoxFull Year Results
Mid Wynd International Investment TrustHalf Year Results
SeniorFull Year Results
Tuesday 3 March 
IntertekFull Year Results
John Laing GroupFull Year Results
XP PowerFull Year Results
4imprint GroupFull Year Results
Cairn HomesFull Year Results
FresnilloFull Year Results
Ashtead GroupQ3 Results
Hutchison ChinaFull Year Results
Direct Line InsuranceFull Year Results
Greggs Full Year Results
HuntsworthFull Year Results
Travis PerkinsFull Year Results
GoCo GroupFull Year Results
DX GroupHalf Year Results
Robert WaltersFull Year Results
RotorkFull Year Results
KellerFull Year Results
Apax Global AlphaFull Year Results
CranewareHalf Year Results
IbstockFull Year Results
International Game TechnologyQ4 Results
IWGFull Year Results
Wednesday 4 March 
BATM AdvancedFull Year Results
Allergy TherpeutucsHalf Year Results
Hostelworld GroupFull Year Results
Mpac GroupFull Year Results
Crystal Amber FundHalf Year Results
Vivo EnergyFull Year Results
Legal & GeneralFull Year Results
Polymetal InternationalFull Year Results
TT ElectronicsFull Year Results
BiffaTrading Statement
Hill & Smith HoldingsFull Year Results
ElementisFull Year Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
26 Sep 2016 14:24

Allergy Therapeutics swings to FY loss on R&D spend

(ShareCast News) - Allergy Therapeutics posted a rise in revenue for the year to the end of June but said it swung to a loss as it ramped up its spending on research and development. Revenue rose 12% from 2015 to £48.5m but the company reported a pre-tax loss of £12.1m versus a profit of £654,000 th

Read more
26 Sep 2016 09:46

Numis reiterates 'buy' on Allergy Therapeutics after full year results

(ShareCast News) - Numis reiterated a 'buy' rating and target price of 37p on Allergy Therapeutics on Monday after the company reported its full year results. Allergy reported a 19% increase in revenue at constant currency to £51.5m in the year ended 30 June as it grew market share in its main Europ

Read more
13 Jul 2016 08:43

Allergy Therapeutics Expects Revenue Rise Despite Euro Weakening

Read more
8 Jul 2016 14:02

Allergy Therapeutics sees good results from Acarovac Plus

(ShareCast News) - Specialty pharmaceutical company Allergy Therapeutics published a one-year follow up study of patients using Acarovac Plus on Friday, in the peer-review journal Immunotherapy. The AIM-traded firm's Acarovac Plus product was described as a microcrystalline tyrosine-adsorbed, house

Read more
8 Jul 2016 07:26

Allergy Therapeutics Welcomes Positive Follow-Up Results For Acarovac

Read more
27 Jun 2016 09:51

WINNERS & LOSERS SUMMARY: easyJet And Foxtons In Post-Brexit Warnings

Read more
27 Jun 2016 09:06

Allergy Therapeutics Sees Delayed US Market Launch For GrassMATAMPL

Read more
10 Jun 2016 07:41

Allergy Therapeutics Appoints Skyepharma's Wykeman As Finance Director

Read more
9 May 2016 06:57

Allergy Therapeutics Gets Positive Birch Pollen Treatment Results

Read more
5 Apr 2016 08:12

NetScientic Poaches New Finance Boss From Allergy Therapeutics

Read more
17 Mar 2016 09:08

Allergy Therapeutics Finance Director Ian Postlethwaite Resigns

Read more
10 Mar 2016 09:33

BROKER RATINGS SUMMARY: Jefferies Starts Metro Bank With Buy Rating

Read more
8 Mar 2016 10:59

Allergy Therapeutics Profit Drops On Higher Costs As Revenue Edges Up

Read more
18 Feb 2016 08:08

Allergy Therapeutics Completes Enrolment For Grass Pollen Drug Study

Read more
13 Jan 2016 09:38

Allergy Therapeutics Revenue Up In First Half, Full Year Seen In Line

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.